Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-22

Clinical Trial Update: Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and Transfusion [NA]

View source ↗

Summary

A completed clinical trial examined whether tranexamic acid can reduce bleeding and transfusion needs in patients exposed to clopidogrel with coronary artery di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Coronary Artery Disease | NA | Status: COMPLETED